Canada markets closed

Telomir Pharmaceuticals, Inc. (TELO)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
5.50-0.13 (-2.31%)
At close: 04:00PM EDT
5.30 -0.20 (-3.64%)
After hours: 05:55PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
Total Revenue
0
0
0
0
Operating Expenses
Research Development
1,938
1,574
833.206
126.492
Selling General and Administrative
1,299
600.192
20.941
11.639
Total Operating Expenses
5,375
3,942
854.147
138.131
Operating Income or Loss
-5,375
-3,942
-854.147
-138.131
Interest Expense
5,982
1,643
0
-
Total Other Income/Expenses Net
-
-7,487
-
-
Income Before Tax
-18,844
-13,072
-854.147
-138.131
Income from Continuing Operations
-18,844
-13,072
-854.147
-138.131
Net Income
-18,844
-13,072
-854.147
-138.131
Net Income available to common shareholders
-18,844
-13,072
-854.147
-138.131
Basic EPS
-0.14
-0.44
-0.03
-0.00
Diluted EPS
-0.14
-0.44
-0.03
-0.00
Basic Average Shares
29,610
29,610
29,610
29,610
Diluted Average Shares
29,610
29,610
29,610
29,610